<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Amiodarone</id>
	<title>Amiodarone - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Amiodarone"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Amiodarone&amp;action=history"/>
	<updated>2026-04-25T18:22:53Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Amiodarone&amp;diff=5368974&amp;oldid=prev</id>
		<title>Prab at 04:41, 6 March 2024</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Amiodarone&amp;diff=5368974&amp;oldid=prev"/>
		<updated>2024-03-06T04:41:23Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Amiodarone.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Amiodarone&amp;#039;&amp;#039;&amp;#039; is a [[medication]] used in the treatment of various types of [[tachyarrhythmia]], an abnormal fast rhythm of the heart. It is a class III [[antiarrhythmic agent]] and is used in situations where other medications are either not effective or are contraindicated.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
Amiodarone works by prolonging the duration of the [[action potential]] of [[cardiac tissue]] and by prolonging the refractory period of the [[heart&amp;#039;s electrical conduction system]]. It achieves this by inhibiting [[potassium channels]], which are responsible for repolarization of the heart following a heartbeat. This results in a slowing of the heart rate and a reduction in the occurrence of abnormal heart rhythms.&lt;br /&gt;
&lt;br /&gt;
[[File:Amiodarone 3.jpg|thumb|Amiodarone 3]]&lt;br /&gt;
==Medical uses==&lt;br /&gt;
Amiodarone is primarily used to treat a variety of heart rhythm disorders such as [[ventricular tachycardia]] and [[ventricular fibrillation]]. It is also used in the treatment of wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. It is often used when other medications have failed to control the heart rhythm disorder.&lt;br /&gt;
&lt;br /&gt;
==Side effects==&lt;br /&gt;
The use of Amiodarone can be associated with several side effects. These can include [[nausea]], [[vomiting]], [[constipation]], and anorexia. More serious side effects can include [[pulmonary toxicity]], [[thyroid dysfunction]], and [[liver toxicity]]. Due to these potential side effects, monitoring is required during treatment with Amiodarone.&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
Amiodarone was initially developed in 1961 in Belgium. It was initially used as a treatment for angina, but its antiarrhythmic properties were discovered by chance. It was approved for medical use in the United States in 1985.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[Antiarrhythmic agent]]&lt;br /&gt;
* [[Tachyarrhythmia]]&lt;br /&gt;
* [[Ventricular tachycardia]]&lt;br /&gt;
* [[Ventricular fibrillation]]&lt;br /&gt;
&lt;br /&gt;
{{Antiarrhythmic agents}}&lt;br /&gt;
{{Emergency medicine}}&lt;br /&gt;
{{Ion channel modulators}}&lt;br /&gt;
{{Monoamine reuptake inhibitors}}&lt;br /&gt;
{{Xenobiotic-sensing receptor modulators}}&lt;br /&gt;
{{Portal bar|Medicine}}&lt;br /&gt;
{{coststubd}}&lt;br /&gt;
[[Category:Diethylamino compounds]]&lt;br /&gt;
[[Category:Antiarrhythmic agents]]&lt;br /&gt;
[[Category:Diarylketones]]&lt;br /&gt;
[[Category:Chemical substances for emergency medicine]]&lt;br /&gt;
[[Category:CYP2D6 inhibitors]]&lt;br /&gt;
[[Category:CYP3A4 inhibitors]]&lt;br /&gt;
[[Category:Hepatotoxins]]&lt;br /&gt;
[[Category:Iodoarenes]]&lt;br /&gt;
[[Category:Piceol ethers]]&lt;br /&gt;
[[Category:2-Phenoxyethanamines]]&lt;br /&gt;
[[Category:Potassium channel blockers]]&lt;br /&gt;
[[Category:VMAT inhibitors]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>